Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of Anebulo Pharmaceuticals, Inc. on Form S-1 to be filed on or about April 1, 2021 of our report dated December 18, 2020, on our audit of the financial statements as of June 30, 2020, and for the period from April 23, 2020 (inception) through June 30, 2020. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
April 1, 2021
